Effect of coordinated support for tumor patients by repetitive offers: a prospective randomized controlled trial.

Not Applicable

• Conditions: C16.9; C20; C18.9; C25.9; Stomach, unspecified; Malignant neoplasm of rectum; Colon, unspecified; Pancreas, unspecified

• Registration Number: DRKS00011183
• Lead Sponsor: Juliusspital Würzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

All newly diagnosed patients with gastric, pancreatic and colorectal cancer (independent of stage and therapy) are included.
Inclusion criteria are also: Mental ability to consent formally, Age between 18 and 80 years at study entry, Estimated life expectancy of 15 months or more (in the palliative setting)

Exclusion Criteria

Exclusion criteria are Lack of mental ability to consent formally, Age younger than 18 or older than 80 years at study entry, Estimated life expectancy of less than 15 months (in the palliative setting)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The patient's psychosocial burden is measured at time point 0 and after 3 1/2, 6 1/2 und 9 1/2 months using the German Version of the Distress Thermometer.

Secondary Outcome Measures

Name	Time	Method
Secondary end points are measured at time point 0 and after 3 1/2, 6 1/2 und 9 1/2 months. These include Quality of life by the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 Score, physical fitness by the ECOG performance Status, malnutrition by the Nutrition Risk Score (NRS).